title: MHC-binding peptides as immunotherapeutics for cancer.
authors.affiliation: Department of Immunology and Mayo Graduate School, Mayo Clinic, Rochester, MN 55905, USA.
authors.forename: H
authors.initials: H
authors.lastname: Kobayashi
authors.forename: R
authors.initials: R
authors.lastname: Kennedy
authors.forename: J
authors.initials: J
authors.lastname: Lu
authors.forename: E
authors.initials: E
authors.lastname: Davila
authors.forename: E
authors.initials: E
authors.lastname: Celis
mesh_terms: D000951:Antigens, Neoplasm / Q000378:metabolism*; D002272:Carcinoembryonic Antigen / Q000276:immunology; D003602:Cytotoxicity, Immunologic; D000939:Epitopes / Q000378:metabolism; D015395:Histocompatibility Antigens Class I / Q000378:metabolism*; D000949:Histocompatibility Antigens Class II / Q000378:metabolism*; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D066298:In Vitro Techniques; D009363:Neoplasm Proteins / Q000276:immunology; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D010455:Peptides / Q000276:immunology* / Q000378:metabolism*; D011485:Protein Binding; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000276:immunology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology
chemical_list: D000951:Antigens, Neoplasm; D002272:Carcinoembryonic Antigen; D000939:Epitopes; D015395:Histocompatibility Antigens Class I; D000949:Histocompatibility Antigens Class II; D009363:Neoplasm Proteins; D010455:Peptides; D018719:Erb-b2 Receptor Tyrosine Kinases; C072012:MAGEB2 protein, human